Proof-of-concept Clinical Trial: Prevent Cognitive Decline in GBA-Associated Parkinson's Disease

被引：0
|
作者：
Brockmann, K.
Corvol, J. C.
DiFonzo, A.
Durrleman, S.
Gasser, T.
Hu, M.
Krueger, R.
Liepelt-Scarfone, I.
Matarazzo, M.
Pilotto, A.
Simuni, T.
Svenningsson, P.
Weintraub, D.
Pagano, G.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
32
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [21] Glucosylsphingosine accelerates α-synuclein pathology in GBA-associated Parkinson disease
    Taguchi, Yumiko V.
    Liu, Jun
    Ruan, Jiapeng
    Pacheco, Joshua
    Zhang, Xiaokui
    Abbasi, Justin
    Keutzer, Joan
    Mistry, Pramod K.
    Chandra, Sreeganga S.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S129 - S129
  • [22] Phenotypic characteristics in GBA-associated Parkinson's disease (PD): A study in a Greek population
    Simitsi, A. M.
    Koros, C.
    Papagiannakis, N.
    Antonelou, R.
    Moraitou, M.
    Michelakakis, H.
    Stamelou, M.
    Stefanis, L.
    MOVEMENT DISORDERS, 2016, 31 : S202 - S202
  • [23] Involvement of the genes related to lysosomal storage disorders in GBA-associated Parkinson's disease
    Bezrukova, A.
    Bogdanova, D.
    Basharova, K.
    Senkevich, K.
    Gracheva, E.
    Miliukhina, I.
    Pchelina, S.
    Usenko, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 44 : S1 - S2
  • [24] Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients
    Slingerland, Sofie
    van der Zee, Sygrid
    Carli, Giulia
    Slomp, Anne C.
    Boertien, Jeffrey M.
    d'Angremont, Emile
    Bohnen, Nicolaas, I
    Albin, Roger L.
    van Laar, Teus
    BRAIN, 2024, 147 (03) : 900 - 910
  • [25] Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk
    Straniero, Letizia
    Rimoldi, Valeria
    Monfrini, Edoardo
    Bonvegna, Salvatore
    Melistaccio, Giada
    Lake, Julie
    Solda, Giulia
    Aureli, Massimo
    Shankaracharya
    Keagle, Pamela
    Foroud, Tatiana
    Landers, John E.
    Blauwendraat, Cornelis
    Zecchinelli, Anna
    Cilia, Roberto
    Di Fonzo, Alessio
    Pezzoli, Gianni
    Duga, Stefano
    Asselta, Rosanna
    MOVEMENT DISORDERS, 2022, 37 (06) : 1202 - 1210
  • [26] Therapy to Reduce dementia risk In Parkinson's disease (TRIP): Proof-of-concept trial
    Pourzinal, D.
    Bakker, A.
    Byrne, G.
    McMahon, K.
    O'Sullivan, J.
    Adam, R.
    Lehn, A.
    Copland, D.
    Yang, J.
    Pontone, G.
    Au, T.
    Littleford, R.
    Chatfield, M.
    Mari, Z.
    Dissanayaka, N.
    MOVEMENT DISORDERS, 2021, 36 : S191 - S191
  • [27] Analogy learning in Parkinson's disease: A proof-of-concept study
    Jie, Li-Juan
    Goodwin, Victoria
    Kleynen, Melanie
    Braun, Susy
    Nunns, Michael
    Wilson, Mark
    INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 2016, 23 (03): : 123 - 130
  • [28] Ambroxol as a Disease-Modifying Treatment to Reduce the Risk of Cognitive Impairment in GBA-Associated Parkinson's Disease: The AMBITIOUS Study Protocol
    Colucci, F.
    Avenali, M.
    De Micco, R.
    Bacila, A.
    Cerri, S.
    Cuconato, G.
    Franco, V.
    Franciotta, D.
    Ghezzi, C.
    Gastaldi, M.
    Galandra, C.
    Germani, G.
    Mitrotti, P.
    Ongari, G.
    Palmieri, I.
    Picascia, M.
    Pichiecchio, A.
    Esposito, F.
    Cirillo, M.
    Di Nardo, F.
    Aloisio, S.
    Siciliano, M.
    Poli, M. Fusar
    Stanziano, M.
    Garavaglia, B.
    Cazzaniga, F.
    Reale, C.
    Tramacere, I.
    Priori, S.
    Amami, P.
    Piacentini, S.
    Bruzzone, M. G.
    Grisoli, M.
    Moda, F.
    Eleopra, R.
    Tessitore, A.
    Valente, E. M.
    Cilia, R.
    MOVEMENT DISORDERS, 2023, 38 : S19 - S20
  • [29] iPSC-derived in vitro striatal circuits to understand GBA-associated Parkinson's disease
    Do, Quyen
    Ng, Bryan
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 96 - 97
  • [30] Clinical features of GBA associated Parkinson's disease
    Senkevich, K.
    Beletskaia, M.
    Kudrevatykh, A.
    Gracheva, E.
    Emelyanov, A.
    Miliukhina, I.
    Pchelina, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S658 - S658
12345